Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes.
about
Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer's Disease.Antidiabetic Drugs in Alzheimer's Disease: Mechanisms of Action and Future Perspectives.Capsaicin reduces Alzheimer-associated tau changes in the hippocampus of type 2 diabetes ratsPPG neurons of the lower brain stem and their role in brain GLP-1 receptor activation.Type 2 diabetes-induced neuronal pathology in the piriform cortex of the rat is reversed by the GLP-1 receptor agonist exendin-4.Mild traumatic brain injury-induced hippocampal gene expressions: The identification of target cellular processes for drug development.Glycation in Parkinson's disease and Alzheimer's disease.Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer's disease pathology.Reduction of Cognitive Decline in Patients with or at High Risk for Diabetes.Apomorphine Therapy for Neuronal Insulin Resistance in a Mouse Model of Alzheimer's Disease.Brain GLP-1/IGF-1 Signaling and Autophagy Mediate Exendin-4 Protection Against Apoptosis in Type 2 Diabetic Rats.VariFunNet, an integrated multiscale modeling framework to study the effects of rare non-coding variants in Genome-Wide Association Studies: applied to Alzheimer's Disease.Sweet Mitochondria: A Shortcut to Alzheimer's Disease.
P2860
Q33628048-7DE0AD31-3DF3-4B54-8AC2-B9116CF526F5Q33800802-39C17CB1-6A3E-462A-81BB-7DADA869D477Q36287492-4AE7C57D-6A5D-49D3-8E19-318C1A6ED124Q36339320-39DD5059-8C51-4042-AFB0-B90B9D64B587Q36905790-7FBD449F-4E1A-4187-BFD5-8309EEB15F59Q38451090-B22837F1-C5FB-486A-B6FD-6D8D6F03B5ECQ38762228-0E33675A-C47A-4523-9E66-7B7C5E3F66BDQ38974881-FF9A7440-39BB-48A7-B8C0-B9F33BD4C93EQ49687656-7AB5C673-4B7B-49EB-B688-00665C1B4F5FQ50582002-D1830455-0E20-41EE-A0C9-39126DEDFBF0Q50963300-7AB2CC67-47C0-4CBF-A410-E6611F7DC66CQ52310268-652727C9-26F8-4977-8CA7-3314AA132E8AQ55306046-B418F493-FE5A-409F-BF6F-83B7CED503AB
P2860
Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Exendin-4, a glucagon-like pep ...... of rats with type 2 diabetes.
@en
Exendin-4, a glucagon-like pep ...... of rats with type 2 diabetes.
@nl
type
label
Exendin-4, a glucagon-like pep ...... of rats with type 2 diabetes.
@en
Exendin-4, a glucagon-like pep ...... of rats with type 2 diabetes.
@nl
prefLabel
Exendin-4, a glucagon-like pep ...... of rats with type 2 diabetes.
@en
Exendin-4, a glucagon-like pep ...... of rats with type 2 diabetes.
@nl
P2093
P2860
P1476
Exendin-4, a glucagon-like pep ...... of rats with type 2 diabetes.
@en
P2093
P2860
P304
P356
10.1097/JIM.0000000000000129
P577
2015-02-01T00:00:00Z